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The protein products of several rad checkpoint genes of Schizosaccharomyces pombe (rad1ⴙ, rad3ⴙ, rad9ⴙ,
rad17ⴙ, rad26ⴙ, and hus1ⴙ) play crucial roles in sensing changes in DNA structure, and several function in the
maintenance of telomeres. When the mammalian homologue of S. pombe Rad9 was inactivated, increases in
chromosome end-to-end associations and frequency of telomere loss were observed. This telomere instability
correlated with enhanced S- and G2-phase-specific cell killing, delayed kinetics of ␥-H2AX focus appearance
and disappearance, and reduced chromosomal repair after ionizing radiation (IR) exposure, suggesting that
Rad9 plays a role in cell cycle phase-specific DNA damage repair. Furthermore, mammalian Rad9 interacted
with Rad51, and inactivation of mammalian Rad9 also resulted in decreased homologous recombinational
(HR) repair, which occurs predominantly in the S and G2 phases of the cell cycle. Together, these findings
provide evidence of roles for mammalian Rad9 in telomere stability and HR repair as a mechanism for
promoting cell survival after IR exposure.
in either the rad1⫹, the hus1⫹, the rad9⫹, or the rad17⫹ gene;
S. cerevisiae with mutations in related orthologues; and nematodes altered in mrt-2 (encoding a Rad1 homolog) show telomere shortening; however, S. cerevisiae with mutant Mec3
shows telomere elongation, suggesting that these checkpoint
proteins are also involved in telomere maintenance (1, 9, 11,
28, 36). Nabetani and coworkers (35) have found that hRad9,
along with hHus1 and hRad1, is colocalized specifically at
telomeric DNAs and promyelocytic leukemia bodies in ALT
(alternative lengthening of telomeres) cells. Whether these
observations are functionally significant in relation to telomere
instability is unknown.
Genomic stability is maintained by telomeres since these
chromosomal terminal structures protect chromosomes from
fusion or degradation, as initially reported by Muller (34) and
McClintock (32). Shortening or loss of telomeric repeats or
altered telomere chromatin structure is correlated with chromosome end-to-end associations that could lead to genomic
instability and gene amplification (10, 14, 39). Increased chromosome end-to-end associations, also known as telomeric associations typically seen at metaphase, have been reported in
cells derived from tumor tissues, in senescent cells, in the
Thiberge-Weissenbach syndrome, in A-T individuals, and following viral infections (45, 56). Chromosome end-to-end associations have been linked to genomic instability and carcinogenicity (10, 15, 38, 39). Both genetic and epigenetic factors
can influence telomere stability (26, 55). For example, telomeric end-to-end fusions are enhanced in cells expressing
dominant negative alleles of human telomeric protein TRF2 or
overexpressing isoforms of human HP1 proteins (55, 64). Al-

The DNA damage checkpoint pathways are highly conserved among a wide range of eukaryotes, from Saccharomyces
cerevisiae to mammals. Human Rad9 (hRad9) is phosphorylated by ATM (ataxia-telangiectasia [A-T] mutated gene product) in response to DNA damage (7). Together with hRad1
and hHus1, hRad9 forms a nuclear complex that resembles
PCNA and is believed to sense DNA damage (60, 65, 66).
However, the cellular colocalization of hRad9 with the phosphorylated form of histone H2A variant X (␥-H2AX) after
DNA damage is independent of ATM function (19), raising
the possibility that hRad9 may also have a direct DNA damage-sensing function. In addition, Yin and coworkers (71) have
reported that hRad9, much like p53, can transactivate p21.
Loss of DNA damage response elements can result in cancer
and other genetic diseases (22, 38). In fact, aberrant expression
of Mrad9 or hRad9 has been linked to morphological transformation and cancer (8, 30, 59). Inactivation of Mrad9 in
mouse embryonic stem (ES) cells results in an increased frequency of spontaneous chromosomal aberrations (23), and
similar findings were observed in human cells with reduced
levels of hRad9 (12). However, it is not known exactly how
mammalian Rad9 influences genomic instability and whether
the mechanism is related to defective DNA double-strand
break (DSB) repair.
Interestingly, strains of Schizosaccharomyces pombe mutated
* Corresponding author. Mailing address: Department of Radiation
Oncology, Washington University School of Medicine, 4511 Forest
Park Ave., St. Louis, MO 63108. Phone: (314) 747-5461. Fax: (314)
362-9790. E-mail: pandita@wustl.edu.
† R.K.P. and G.G.S. contributed equally to this work.
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though recent data support a role for hRad9 in the cellular
response to DNA damage, it is not clear whether this protein
functions in telomere maintenance or DNA damage repair
following ionizing radiation (IR) exposure. Here we report
that inactivation or reduction in levels of mammalian Rad9
enhances telomere instability, increases cell killing by IR specifically in the S and G2 phases of the cell cycle, and reduces
DNA DSB repair by homologous recombination (HR).

rings, and terminal deletions. S-phase-type chromosome aberrations were assessed by counting both the chromosome and chromatid aberrations per metaphase as previously described (24, 55). G2-type chromosomal aberrations were
assessed by counting chromatid breaks and gaps per metaphase as previously
described (24, 55). The efficiency of the G1- or S-phase checkpoint was determined as previously described (24). The efficiency of G2 checkpoint control was
evaluated by comparing different cell types for mitotic indices and chromatidtype aberrations at metaphase after irradiation (13). Fifty metaphases were
scored for each postirradiation time point.
PCC. The technique of PCC was used to visualize chromosome damage directly in G1- and G2-phase cell populations (43, 44). The procedures employed
for mitotic Chinese hamster ovary (CHO) cell accumulation, cell fusion, and
chromosome preparations are the same as previously described (43). G1- and
G2-phase cell populations were obtained by centrifugal elutriation, placed on ice,
irradiated, and fused with mitotic CHO cells to induce PCC. Chromosome
damage in G1-phase cells is seen in the G1-phase PCC as an increase in the
number of chromosome fragments per cell as previously described (43). For
treated cells in the G1 phase, the number of breaks per cell was determined by
subtracting the number of chromosome fragments per cell in unirradiated cells
from that found in irradiated cells. Chromosome damage in G2-phase cells is
seen as an increase in breaks, gaps, and exchanges. For treated cells in the G2
phase, the numbers of chromatid gaps, breaks, and exchanges were determined
by subtracting the number of such aberrations per cell in the unirradiated
populations from that in irradiated cells.
Antibodies and immunoprecipitation. Published protocols were used for immunoprecipitation and immunoblotting (21). The following antibodies were
used: anti-hRad9 and anti-hRad51from Santa Cruz (Santa Cruz, CA) and ATM,
ATM S-1981, Chk2, TRF2, and Chk2 P-T68 provided by K. D. Brown, T.
deLange, S. Elledge, M. B. Kastan, and J. Chen.
␥-H2AX immunofluorescence measurements. Cells were grown in chamber
slides, fixed in 2% paraformaldehyde for 15 min, washed in phosphate-buffered
saline (PBS), permeabilized for 5 min on ice in 0.2% Triton X-100, and blocked
in PBS with 1% bovine serum albumin. The procedure used for immunostaining
is the same as that described previously (46, 53). Briefly, anti-␥-H2AX antibodies
(Upstate Biotechnology) were applied to cells, which were then incubated for
1 h, washed with PBS containing 1% bovine serum albumin, and further incubated with Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody (Molecular Probes) for 1 h at room temperature. Cells were rinsed with PBS and
mounted in Vectashield mounting medium (Vector Laboratories). For detection
of cells in S phase, cells were labeled with BrdU for 30 min. BrdU was detected
by a monoclonal anti-BrdU antibody (Amersham Pharmacia Biotech) in concert
with Alexa Fluor 594-conjugated goat anti-mouse secondary antibody (Molecular Probes). Foci were counted by microscopic and imaging processes. Fluorescence images were captured by using a Zeiss Axioskop 2 mot epifluorescence
microscope equipped with a charge-coupled device camera and ISIS software
(Metasystems, Altlussheim, Germany). Optical sections through nuclei were
captured, and the images were obtained by projection of the individual sections.
The results shown are from three independent experiments. Cells with a bubblelike appearance or micronuclei were not considered for ␥-H2AX analysis.
In vitro nonhomologous end-joining (NHEJ) assay. hRad9 was immunodepleted from human 293 cell extracts by anti-hRad9 antibody (54), or cell extracts
were made from 293 cells after hRad9 knockdown by siRNA. The end-joining
assay was performed as previously described (5, 54).
HR repair measurement. To determine the chromosomal HR frequency,
MCF-7 cells were transfected with 1 to 3 g of linearized pDR-green fluorescent
protein (pDR-GFP) plasmid using Lipofectamine 2000 (Invitrogen Corporation,
Carlsbad, CA) (48, 72). Stably transfected cell lines were selected by growth in
medium containing 1.0 g/ml puromycin. Selected pDR-GFP-containing clones
were shown to exhibit I-SceI-inducible HR, which produces GFP-positive cells
detected by flow cytometry. Fifty-two hours posttransfection with either control
siRNA or hRad9 siRNA, the cells were transfected with I-SceI expression vector
pCMV3xn-1-SceI or a control cytomegalovirus vector. pGFP, containing the
full-length GFP cDNA, was transfected into these cells as a calibration control
for GFP-positive cells and to ensure that the transient transfection resulted in
equal expression frequencies in the siRNA-treated cells. Seventy-two hours after
I-SecI transfection, cells were trypsinized to form a single-cell suspension in
Dulbecco modified Eagle medium and subjected to flow cytometric analysis.
Two-color (green and propidium red) fluorescence analysis revealed the percentage of green fluorescent cells relative to the total cell number (48, 72). For
each analysis, 100,000 cells were processed and each experiment was repeated
three times.
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MATERIALS AND METHODS
Cells and transfection. Human 293, GM5823⫹hTERT, MCF-7, and GM847
cells were maintained by previously published procedures (41, 55). Mouse ES
cells were cultured by standard methods (23). Full-length hRad9 cDNA and
DNA encoding the hRad9 C-terminal fragment (269 to 391 amino acids [aa];
⌬hRad9) were amplified by reverse transcription-PCR, cloned into pcDNA3.1,
and transfected into cells (67). hRad9 small interfering RNA (siRNA) and
control Luc siRNA were obtained from Dharmacon Research (Lafayette, CO).
The siRNA sequence targeting hRad9 was 5⬘-AACCCUUGGAGGACGGGC
UCU-3⬘.
Clonogenic assays. Cells were plated onto 60-mm dishes in 5.0 ml of medium,
incubated for 6 h, and subsequently exposed to IR. The number of cells per dish
was chosen to ensure that about 50 colonies would survive a particular radiation
dose treatment. Cells were exposed to IR in a dose range of 0 to 6 Gy at room
temperature. Cells were incubated for 12 or more days and then fixed in methanol-acetic acid (3:1) prior to staining with crystal violet. Only colonies containing ⬎50 cells were counted.
Detection of telomeres and determination of telomere restriction fragment
length. Telomeres in metaphase spreads were detected by fluorescent in situ
hybridization (FISH) with a telomere-specific probe (55). To identify association
between two human chromosomes, we used centromere and telomere probe
combinations. Centromere-specific PNA probes were labeled with fluorescein
isothiocyanate (green), and telomere-specific PNA probes were labeled with the
fluorochrome Cy3 (red). For terminal restriction fragment (TRF) length analysis, DNA was isolated from exponentially growing cells, the DNA was digested
with the restriction enzymes RsaI and HinfI (which do not cut the terminal
TTAGGG repeat sequences), and the resulting DNA fragments were separated
by agarose gel electrophoresis and then hybridized to a 32P-labeled (TTAGGG)5
probe (13). TRF detection and measurement of TRF lengths were performed as
described previously, with ImageQuant version 1.2 (Molecular Dynamics) (13,
33, 54, 55). Nondenaturing in-gel hybridization to determine relative amounts of
telomeric single-stranded DNA (G tails) was performed as described previously
(33).
Telomerase assay. Telomerase activity was determined with the telomerase
PCR enzyme-linked immunosorbent assay kit (Boehringer Mannheim) as previously described (52). Telomerase activity was determined in triplicate, and
negative and positive controls were run with each experiment. As a negative
control, an aliquot of each extract was heat inactivated for 10 min at 95°C.
Cell synchronization. To obtain cell samples enriched at different phases of
the cell cycle, exponentially growing populations were fractionated by centrifugal
elutriation (44). The cell cycle distribution of the fractionated samples was
determined by flow cytometry measurements of DNA content (43, 44), as well as
by using a premature chromosome condensation (PCC) protocol (43).
Chromosome studies. Metaphase chromosomes were prepared by standard
procedures (45). Giemsa-stained chromosomes from metaphase spreads were
analyzed for chromosome end-to-end associations and aberrations. PCC was
used to visualize chromosome damage directly in G1- and G2-phase cell populations. However, after S-phase-specific PCC, chromosomes look pulverized and
therefore could not be analyzed for chromosome breaks (43, 44).
Assay for G1, S, and G2 chromosomal aberrations at metaphase and checkpoints. G1-type chromosomal aberrations were assessed in cells exposed to 3 Gy
of IR and incubated for 24 h. Cells were then subcultured, and metaphases were
collected (24, 55). S-phase-specific chromosome aberrations were assessed after
exponentially growing cells (pulse-labeled with bromodeoxyuridine [BrdU]) were
irradiated with 2 Gy of IR. Metaphases were harvested following 4 h of irradiation, and S-phase types of chromosomal aberrations were scored. For G2specific aberrations, cells were irradiated with 1 Gy and metaphases were collected 45 and 90 min posttreatment (13). Chromosome spreads were prepared
after hypotonic treatment of cells, fixed in acetic acid-methanol, and stained with
Giemsa (37). The categories of G1-type asymmetrical chromosome aberrations
that were scored included dicentrics, centric rings, interstitial deletions/acentric
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RESULTS
hRad9 has been reported to localize on telomeres in cells
that maintain telomeres by the telomerase-independent pathway known as ALT (35). To determine whether overexpression
of hRad9 or its inactivation influences telomere stability, we
overexpressed wild-type hRad9 and a mutant form of hRad9
(hRad9 C-terminal fragment [261 to 391 aa; ⌬hRad9]) in cells
and monitored telomere fusions at metaphase. We selected
three different cell lines to study the effect of ⌬hRad9 on
telomeres, because in 293 and MCF-7 cells, telomeres are
maintained by telomerase, whereas in GM847 cells, telomeres
are maintained by the alternative mechanism (ALT). Cells
ectopically expressing hRad9 had about threefold more of the
encoded protein than did the parental cells (Fig. 1A and data
not shown). Expression of ⌬hRad9 did not influence levels of
endogenous hRad9. Furthermore, the levels of endogenous
hRad9 were similar in different phases of the cell cycle and
were unaffected by expression of ⌬hRad9 (Fig. 1B). 293 cells
overexpressing hRad9 exhibited telomere association (TA) frequencies similar to those of control cells, suggesting that an
increase in the hRad9 level in these cells has no influence on
telomere stability. However, as shown in Table 1, in cells expressing ⌬hRad9, there was a significant increase in TA per
metaphase (range of 0.65 to 1.1) relative to the frequency

observed for the parental cells (range of 0.09 to 0.13). These
TAs were random. Mutant ⌬hRad9 tagged with HA localized
to the nucleus as detected by immunostaining (data not shown)
had no influence on endogenous hRad9 levels (Fig. 1A), suggesting that the truncated protein may have a dominant negative effect. Since chromosome end-to-end associations may
lead to anaphase bridge formation, the same cells were analyzed for this aberration. For each case, 300 cells at anaphase
were examined for bridges. Cells expressing ⌬hRad9 displayed
a two- to fourfold higher frequency of anaphase bridges in
comparison to parental cells (Table 1).
The presence of ⌬hRad9 may produce nonspecific effects
that could complicate the interpretation of experimental results. Therefore, we used RNA interference-mediated hRad9
knockdown to confirm independently the dominant negative
data. Cells transfected with hRad9-specific siRNA had an 80%
reduction in hRad9 levels 48 h after transfection (Fig. 1C).
When examined for telomere end associations, these cells gave
results similar to those obtained for cells with ⌬hRad9 (Table
1).
The chromosome end-to-end association data described
above suggest that, due to loss of telomere function, chromosome end associations are formed and that these associations
are not resolved in cells devoid of normal levels of Rad9. To
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FIG. 1. Expression of hRad9. (A) hRad9 protein levels were detected by Western analysis with hRad9-specific antibody in human 293 cells.
hRad9 levels in cells expressing mutant (⌬) and wild-type hRad9 are shown. Higher levels of the protein were detected in cells engineered to
overexpress hRad9, relative to the vector control, but no difference in hRad9 levels was seen in cells ectopically expressing ⌬hRad9. (B) hRad9
levels in different phases of the cell cycle as detected in cell extracts of human 293 cells by immunoblotting with anti-hRad9 antibody. Human 293
cells in different phases were enriched by centrifugal elutriation (41). Lane 1 represents an asynchronous population, lane 2 represents a
G1-phase-enriched population, lane 3 represents an S-phase-enriched population, and lane 4 represents a G2/M-phase-enriched cell population.
(a) hRad9 levels in cells in different phases of the cell cycle. (b) hRad9 levels in cells expressing ⌬hRad9 in different phases of the cell cycle. No
difference in the levels of hRad9 was seen in different phases of the cell cycle. (C) siRNA-mediated reduction of hRad9 protein in 293 and MCF-7
cells. Cells were transfected with siRNA, and cell lysates were made 48 h posttransfection and examined for hRad9 protein by immunoblotting with
anti-hRad9 antibody.
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TABLE 1. Frequencies of chromosomal aberrations in cells with or without functional Rad9a
Chromosome end
associations/200
metaphases

Bridges/300
anaphases

Chromosome gaps ⫹
breaks/200
metaphases

Chromatid gaps ⫹
breaks/200
metaphases

293
293 ⫹ empty vector
293 ⫹ ⌬hRad9
293 ⫹ hRad9
293 (hRad9 siRNA)
293 (control siRNA)
GM847
GM847 ⫹ empty vector
GM847 ⫹ ⌬hRad9
MCF (control siRNA)
MCF (hRad9 siRNA)
GM5823 (A-T)
Mrad9⫹/⫹
Mrad9⫺/⫺

24
21
78b
23
63b
19
34
31
67b
16
43b
68b
17
55b

16
13
43b
12
51b
14
19
14
39b
11
27b
56b
12
34b

2
3
6
3
5
4
3
4
4
2
6
18b
4
6

3
3
17b
1
11b
2
5
2
14b
4
7
12b
3
18b

a
Chromosome end-to-end associations (telomeric associations), chromosome breaks and gaps, and chromatid breaks and gaps were analyzed at metaphase and
bridges at anaphase in cells with or without functional Rad9.
b
Aberrations in cells expressing ⌬hRad9 or having reduced expression of wild-type Rad9 are significantly different from controls (293 or GM847 cells) as assessed
by chi-square analysis (P ⬍ 0.01). Chromosome aberrations in Mrad9⫺/⫺ cells are significantly higher compared to those observed in Mrad9⫹/⫹ cells.

further examine how expression of ⌬hRad9 or a reduction in
hRad9 levels is linked to telomere dysfunction, we determined
mean TRF sizes. Southern blotting indicated no significant
difference in TRF or G-overhang sizes when comparing DNA
derived from cells with or without expression of ⌬hRad9 or
reduced levels of hRad9 (Fig. 2A). However, this analysis
yields an appraisal only of the entire population of TRFs generated and does not monitor the ends of individual chromosomes. We therefore performed FISH for telomeric repeats on
metaphase spreads by using a telomere-specific Cy3-labeled
(CCCTAA)3 peptide nucleic acid probe. We applied centromere-specific Cy5-labeled FISH to detect human centromeres,
which was used to monitor the hybridization for each chromosome and to visualize whether TA has occurred between two
chromosomes. Fifty metaphase chromosome spreads (about
2,300 to 3,100 chromosomes) from each cell type were included and analyzed. A significantly higher proportion of chromatid ends in cells with aberrant functional hRad9 levels
(about 10% of the telomeres per metaphase) lack telomerespecific fluorescent signals compared to the control cells, in
which only ⬍1% of the chromatids do not show telomere
signals per metaphase (Fig. 2B). The loss of telomere signals
could be a result of breaks adjacent to telomeres or shortened
telomere tracts. These observations indicate that some of the
chromosome end-to-end fusions observed in Rad9-inactivated
cells correlated with loss of telomeric repeats. However, telomere signals were seen in more than 52% of the fusion sites,
indicating that a total loss of telomeres is not required for
telomere fusions in such cell systems.
To provide more evidence for the influence of mammalian
Rad9 on telomere stability, we evaluated mouse ES cells in
which both alleles of Mrad9 were inactivated (23). About 4%
of Mrad9 knockout cells showed chromosomal aneuploidy, as
well as polyploidy (Fig. 2C). Consistent with the influence of
hRad9 on telomere stability in human cells, we also found that
Mrad9 knockout mouse ES cells had a significantly higher
frequency of telomere end associations, as well as loss of telomere signals (Fig. 2C and Table 1). These cells frequently
showed Robertsonian fusions, supporting the argument that

loss of telomeres results in fusions that lead to metacentric
chromosomes (Fig. 2C). Telomere signals were seen in more
than 20% of the fusion sites, indicating that total loss of telomeres is not required for telomere fusions (Fig. 2C).
hRad9 interacts with TRF2 and influences telomere stability. Telomere end association has been correlated with the
inactivation of TRF2 (64). Therefore, we tested whether
hRad9 interacts with TRF2. Analysis of anti-hRad9 immunoprecipitates with anti-TRF2 antibody demonstrated interaction between the two (Fig. 2D). When cells were exposed to
IR, the interaction of hRad9 with TRF2 was unaffected (data
not shown). These observations suggest that interactions of
hRad9 with TRF2 occur prior to induction of DNA damage by
the application of exogenous agents. Since expression of mutant TRF2⌬B⌬M is known to induce telomere fusions (60), we
further tested whether knockdown of hRad9 in cells expressing
mutant TRF2⌬B⌬M will affect telomere function. Cells expressing mutant TRF2⌬B⌬M had more than 60% of their telomeres
dysfunctional. However, cells expressing mutant TRF2⌬B⌬M
and reduced levels of hRad9 had levels of dysfunctional telomeres similar to those seen in cells expressing only mutant
TRF2⌬B⌬M (Fig. 2B). We failed to observe any additional
telomere dysfunction measured by chromosome end fusions in
cells expressing the mutant TRF2⌬B⌬M and knocked-down
hRad9 levels. These results suggest that hRad9 cannot rescue
TRF2-mediated telomere stability.
We next determined whether telomere dysfunction in Rad9deficient cells was due to abnormal telomerase activity. This
activity was compared in vitro in extracts of cells with or without reduced levels of hRad9, and no significant difference was
observed (data not shown). Mrad9⫹/⫹ and Mrad9⫺/⫺ cell extracts also had similar levels of telomerase activity (data not
shown), suggesting that mammalian Rad9 does not influence
telomerase activity, as determined by an in vitro assay.
Recent studies have revealed that Mrad9 knockout ES cells,
relative to Mrad9⫹/⫹ cells, have a higher frequency of spontaneous chromosomal aberrations (23), which correlates with
their telomere instability phenotype. Thus, we determined
whether the frequency of spontaneous chromosome and chro-
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matid aberrations was increased in human cells with inactivated hRad9. Again, cells expressing ⌬hRad9, as well as those
with reduced levels of hRad9 due to the presence of siRNA,
displayed a higher frequency of chromatid, as well as chromo-

some-type, aberrations compared to parental cells (Table 1).
No significant increase in these frequencies was observed in
cells overexpressing hRad9 (Table 1). Thus, mammalian cells
with reduced levels of Rad9 or expression of ⌬hRad9 or inactivated Rad9 expressed had frequent loss of telomere signals,
enhanced telomere fusions, and higher frequencies of chromatid breaks and gaps, but not of chromosomal breaks and gaps,
compared to control cells. Based on these observations of
telomere dysfunction and chromosome aberrations in cells
with inactivated mammalian Rad9, such genomic instability
might be due to defective DNA repair or damage response
checkpoints.
hRad9 knockdown or expression of mutant hRad9 enhances
S- and G2-phase-specific IR-induced cell killing. Rad9 forms a
complex with Hus1 and Rad1 (hRad9-hHus1-hRad1) called
the 9-1-1 complex (73). This complex is loaded onto DNA in
response to many different types of genotoxic stress, including
IR, UV light, replication inhibitors, and alkylation, suggesting
that Rad9 has a role in cellular responses activated by multiple
types of DNA damage (73). Although it is known that Mrad9
inactivation results in enhanced cell killing after IR exposure
(23), it was not known whether Rad9 inactivation affects IR
sensitivity in a specific cell cycle phase.
Telomere instability in mammals can correlate with organismal hypersensitivity to IR (18). Since inactivation of mammalian Rad9 influences telomere stability, we determined
whether overexpression or inactivation of wild-type hRad9 influences cell survival after exposure to IR at a specific cell cycle
phase. Cell survival after IR exposure was determined by using
a colony formation assay described previously (13). Cells overexpressing hRad9 did not exhibit any altered sensitivity to IR
exposure in comparison to the parental cells; however, cells
with hRad9 levels reduced by siRNA, as well as cells expressing
⌬hRad9, demonstrated enhanced cell killing after IR exposure
(Fig. 3A). To define the precise phase of enhanced cell death
after IR exposure, we enriched cells in different phases of the
cell cycle by centrifugal elutriation. The G1-phase-enriched cell
population had about 91% such cells, the S-phase-enriched
population contained greater than 81% cells in S phase, and
the G2/M-phase-enriched population contained 72 to 76%
cells in that phase (data not shown). The survival characteristics of the cells varied through the cell cycle. Expression of
⌬hRad9 did not alter the IR sensitivity of cells in G1 (Fig. 3B).
However, S- and G2-phase cells with inactivated hRad9
showed enhanced IR-induced cell killing relative to control
cells (Fig. 3C and D). These studies indicate that hRad9 has a
specific role in S- and G2-phase cell survival after IR exposure.
We further established that enhanced cell killing in S- and
G2-phase cells was not due to the change in hRad9 levels since
the abundance of this protein was similar in control radioresistant hRad9⫹ cells in different phases of the cell cycle (Fig.
1B).
Mammalian Rad9 influences the appearance and disappearance of IR-induced ␥-H2AX foci. H2AX is associated with
nuclear foci containing factors that are essential for DNA
repair, replication, and cell cycle regulation (17, 49, 50). H2AX
phosphorylation is critical for protecting the genome from
spontaneous DSBs, as well as those induced by IR or V(D)J
recombination (3, 4). H2AX phosphorylation coincides with
the sites of DSBs, irrespective of their origin (6, 29, 47, 51, 69).

Downloaded from http://mcb.asm.org/ on January 10, 2014 by Washington University in St. Louis

FIG. 2. Telomere analysis by single-strand extensions (G tails) and
telomere FISH. (A) G-tail sizes in cells with or without hRad9 inactivation. Detection of sizes of TRFs on DNA derived from 293 cells
with or without hRad9 knockdown. In part a, nondenaturing in-gel
hybridizations to genomic DNA digested with restriction enzymes
HinfI and RsaI and with a telomeric repeat probe of the C-rich strand
are shown. This method allows visualizing G-strand overhangs on
telomeres. Signals were quantified by PhosphorImager analysis and
corrected for DNA loading by using the rehybridized gel shown in part
b. Lane M, molecular mass standards; lane 1, DNA from 293 cells with
empty vector; lane 2, DNA from 293 cells expressing ⌬hRad9; lane 3,
DNA from 293 cells with hRad9 siRNA; lane 4, DNA from 293 cells
with control siRNA; lane ss, denatured plasmid single-stranded DNA
containing telomeric repeats (positive control); lane ds, doublestranded plasmid DNA used as a negative control (detected only once
the DNA is denatured, as shown in part b). Part a shows the same gel
as in part b after denaturing of the DNA in the gel and rehybridization
with the same probe. The arrow in part b indicates an internal restriction fragment carrying telomeric repeats that was used to correct for
DNA loading. (B) Telomere FISH analysis showing human metaphase
chromosomal spreads. Telomere signals are red, and centromere signals are green. Part a, metaphase of 293 cells with empty vector; part
b, metaphase of 293 cells with control siRNA; part c, metaphase
section of MCF-7 cells with control siRNA; part d, metaphase of 293
cells with ⌬hRad9; part e, metaphase section of 293 cells with hRad9
siRNA; part f, metaphase section of MCF-7 cells with hRad9 siRNA;
part g, metaphase section of 293 cells with mutant TRF2⌬B⌬M showing
a chain of chromosomes resulting from single and both TAs; part h,
TA with the interstitial region of a chromatin seen in 293 cells expressing mutant TRF2⌬B⌬M; part i, metaphase of 293 cells with expression
of mutant TRF2⌬B⌬M and knockdown of hRad9 (note that almost all
chromosomes undergo telomere fusions); part j, representative dicentric chromosome with fused telomeres seen in 293 cells expressing
mutant TRF2 and inactivated hRad9. Note chromosome end associations, loss of telomeric signals, and gaps, as indicated by arrows.
(C) Mouse metaphase chromosomes. Part a, representative metaphase
of Mrad9⫹/⫹ cells; part b, Mrad9⫺/⫺ metaphase showing polyploidy;
part c, representative chromosome end association without loss of telomere signal at the association site seen in Mrad9⫺/⫺ cells (Robertsonian
fusion); part d, telomere fusion and loss of telomere signals as indicated
by arrows in Mrad9⫺/⫺ cells. Mrad9⫺/⫺ ES cells have chromosome end
associations, as well as loss of telomeric signals. (D) hRad9 interacts with
TRF2 and Rad51. Immunoprecipitation of endogenous hRad9, TRF2,
and Rad51 in 293 cells. Cell extracts were immunoprecipitated with antihRad9 antibody, followed by immunoblotting with antibodies to TRF2,
Rad51, and hRad9. IgG, immunoglobulin G.
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Since inactivation of Rad9 influences cell survival after IR
exposure and hRad9 colocalizes with ␥-H2AX at DNA DSBs
(19), we examined whether a reduction in hRad9 abundance or
activity can influence the appearance of IR-induced ␥-H2AX
foci. Human 293 cells with reduced hRad9 levels had about
three ␥-H2AX foci per cell 2 min after irradiation with 1 Gy.
Control cells with normal levels of hRad9 had about seven foci
per cell under the same conditions (Fig. 4A). Similar results
were observed in Mrad9⫺/⫺ ES cells, where the appearance of

␥-H2AX foci was delayed compared to that in control
Mrad9⫹/⫹ ES cells (data not shown).
To assess the disappearance of ␥-H2AX foci, we analyzed
human cells 120 and 360 min postirradiation. Furthermore, we
determined whether differences in the appearance of ␥-H2AX
foci after IR exposure are due to cell cycle distribution. To
address this question, we labeled the cells for 30 min with
BrdU, followed by irradiation, and then examined them for
␥-H2AX foci at different times after treatment. Specifically,
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FIG. 3. Comparison of gamma ray sensitivity. Dose-response curves are shown for 293 cells with or without hRad9 knockdown after IR
exposure. The A-T cell line GM5823⫹hTERT was used as a control to indicate radiosensitivity. (A) Survival curves for exponentially growing cells.
Note that cells with hRad9 siRNA or expression of ⌬hRad9 have lower survival after IR treatment. (B to D) Survival through the cell cycle of cells
with or without ⌬hRad9. Dose-response survival curves for cells in the G1 phase (B), the S phase (C), and the G2 phase (D) are shown. The cells
with ⌬hRad9 expression have statistically significantly (P ⬍ 0.01 as determined by the chi-square test) enhanced cell killing compared to control
cells in the S and G2 phases. The values shown are means from three experiments.
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S-phase Mrad9⫺/⫺ cells, as well as human cells with inactivated
hRad9, have a lower number of ␥-H2AX foci compared to
parental control cells (Fig. 4B and data not shown). In general,
the number of ␥-H2AX foci in cells with inactivated mammalian Rad9 was significantly lower until 5 min postirradiation.
However, the ␥-H2AX focus number was higher at 120 min
postirradiation, suggesting that this protein plays a role in
DNA damage repair (Fig. 4A).
IR exposure induces higher frequencies of S- and G2-phasespecific chromosomal aberrations in cells with reduced levels
of hRad9. Telomere instability and IR sensitivity are linked to
defective DNA repair (27, 38, 54, 55, 70). To determine
whether the S- and G2-phase-specific increased cell killing by
IR in cells with reduced levels of hRad9 correlated with DNA
repair, we compared cell cycle stage-specific IR-induced chromosomal aberrations in cells with or without reduced levels of
this protein. We first set out to determine frequencies of chromosomal aberrations induced by IR in G1-, S-, and G2-phase
cells. Cell cycle phase-specific chromosome aberrations were
ascertained based on the frequency of chromosomal and chromatid-type aberrations observed at metaphase. G1-specific aberrations detected at metaphase are mostly of the chromosomal type and include a high frequency of dicentrics (55).
S-phase-type aberrations detected at metaphase are chromo-

somal, as well as those involving chromatids. G2-type aberrations detected at metaphase are predominantly the chromatid
type with the least number of dicentrics. To determine G1-type
chromosome damage, cells were treated with 3 Gy and replated 24 h after irradiation, and aberrations were scored at
metaphase as previously described (24, 55). No difference in
residual IR-induced G1 chromosomal aberrations was seen in
metaphase cells with or without reduced levels of hRad9 (Fig.
5A). Furthermore, cells overexpressing hRad9 did not show
any difference in G1-phase-type chromosome aberrations relative to parental cells after IR exposure (data not shown). To
determine whether defective repair can be documented in cells
overexpressing hRad9 or with ⌬hRad9 in phases of the cell
cycle other than G1, we evaluated S-phase-specific chromosome aberrations. We first determined the time needed for
S-phase cells to reach metaphase after IR treatment. Exponentially growing 293 cells were labeled with BrdU for 30 min
as previously described (55) and then irradiated with 2 Gy.
Anti-BrdU immunostaining was performed to determine when
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FIG. 4. Appearance of ␥-H2AX in cells with or without hRad9.
Cells were irradiated and collected at different times postexposure.
(A) Human 293 cells were irradiated, and ␥-H2AX foci were observed
at various times postirradiation. For each time point, 100 cells were
analyzed. Each experiment was repeated three times. The mean number of foci is plotted against time. Cells with reduced levels of hRad9
caused by hRad9 siRNA showed fewer ␥-H2Ax foci until 5 min postirradiation, and the foci persisted for a longer time. (B) Mouse cells
with or without Mrad9 were grown on coverslips, labeled with BrdU
for 30 min, irradiated with 1 Gy of gamma rays, and processed for
detection of foci as previously described (24, 46). BrdU labeling and
␥-H2AX were detected by anti-BrdU and anti-phospho-histone-H2AX
antibodies, respectively (Upstate).
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FIG. 5. Analysis of chromosome damage and repair in 293 cells with or without wild-type levels of hRad9. (A to C) Chromosomal aberrations
analyzed at metaphase. (A) Cells in plateau phase were irradiated with 3 Gy, incubated for 24 h postirradiation, and then subcultured, and
metaphases were collected. G1-type aberrations were examined at metaphase. All categories of asymmetric chromosome aberrations were scored:
dicentrics, centric rings, interstitial deletions/acentric rings, and terminal deletions. The frequency of chromosomal aberrations was identical for
cells with or without wild-type levels of hRad9, indicating normal repair of G1-phase-specific chromosome damage. (B) Cells in exponential phase
were irradiated with 2 Gy. Metaphases were harvested at 4 h after irradiation, and S-phase types of chromosomal aberrations were scored. Cells
with hRad9 knockdown showed significant differences in chromosomal aberration frequencies compared to control cells (P ⬍ 0.05, Student t test).
(C) Cells in exponential phase were irradiated with 1 Gy. Metaphases were harvested following irradiation, and G2-type chromosomal aberrations
were monitored. Cells with hRad9 knockdown showed significantly higher (P ⬍ 0.05, Student t test) frequencies of chromosomal aberrations
compared to control cells. (D and E) Chromosome break repair in cells in G1- and G2-phase cells. (D) Chromosome break repair in G1-phase cells.
Cells were irradiated with 3 Gy of IR, and chromosome damage was analyzed by a PCC technique. Sixty PCCs were scored for each time point,
and the data represent means and standard deviations of two sets of experiments. The mean number of chromosome breaks per cell immediately
after irradiation was about 12, and this number was reduced after incubation at 37°C. Cells with or without hRad9 knockdown show no difference
in the kinetics or residual levels of breaks. (E) Chromatid gap and break repair in G2-phase cells. Cells were irradiated with 3 Gy of IR, and
chromatid gaps and breaks were analyzed by the PCC technique. The mean number of chromosome breaks per cell immediately after irradiation
was about 10, and this number was reduced after incubation at 37°C. Forty five PCCs were scored for each time point, and the data are the mean
and standard deviation of two sets of triplicate sample experiments. Note that the rate of chromosome repair is slow in cells with Rad9 siRNA,
and such cells have higher frequencies of residual chromosome damage. The difference in residual damage in cells with or without wild-type levels
of hRad9 is statistically significant, as demonstrated by the Student t test (P ⬍ 0.05).
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metaphase chromosomes contain BrdU. In these experiments,
BrdU-labeled metaphases appeared approximately 3 h postirradiation (data not shown). Thus, cells producing hRad9 protein were treated with 2 Gy of IR and metaphases were collected 3 to 5 h postirradiation. Cells overexpressing hRad9 and
collected 3 h postirradiation displayed frequencies of metaphases with chromatid and chromosomal aberrations similar
to those of parental cells (data not shown). In contrast, cells
with reduced levels of hRad9 had significantly higher frequencies of chromosome and chromatid aberrations after IR exposure compared to parental cells (Fig. 5B). Furthermore, when
cells were treated with 1 Gy of gamma rays, hRad9 overexpression had no effect on G2-phase-specific chromosome repair (data not shown), while hRad9 inactivation increased G2phase-specific chromosome aberrations (Fig. 5C). These
observations suggest a role for Rad9 in repairing chromosome
damage in the S, as well as in the G2, phase of the cell cycle.
Reduced levels of hRad9 influence the kinetics of G2-phasespecific but not G1-phase-specific chromosome damage repair.
The underlying reasons for the increased aberrations at mitosis
observed in cells with inactivated Rad9 could be the inability to
modulate cell cycle progression following IR exposure, increased initial levels of genetic damage, and/or decreased efficiency of DNA damage repair. To address whether IR-induced increased initial levels of genetic damage and/or
decreased efficiency of repair is responsible, we used PCC to
visualize directly chromosome events in interphase cells following irradiation (40). G1 chromosomes are rodlike and unreplicated, whereas G2 chromosomes are replicated and have
two chromatids (43). Prematurely condensed chromosomes
from S-phase cells appear fragmented (pulverized) even without irradiation; therefore, S-phase cells cannot be compared.
G1- and G2-phase cells, with or without hRad9, were enriched
by centrifugal elutriation, gamma irradiated, and then allowed
to repair the resulting DNA damage for increasing intervals of
time prior to the induction of PCC. Subsequently, residual

levels of chromosome damage were assessed directly. Cells
with or without reduced levels of hRad9 were irradiated with 3
Gy of gamma rays on ice and then incubated at 37°C for
different periods of time prior to fusion with mitotic cells to
visualize chromosomes. Chromosome fragments were counted
at different time points, and the mean additional number of
fragments seen immediately after irradiation was about 12
higher than the control. No difference in initial chromosome
damage (12 breaks per cell) or the kinetics of chromosome
repair was observed in G1-phase cells with or without normal
Rad9 function (Fig. 5D), consistent with results observed at
metaphase (Fig. 5A). Interestingly, G2-phase cells with Rad9
inactivated had initial chromosome damage (10 breaks) similar
to that of control cells; however, hRad9-deficient cells had a
higher frequency of unrepaired chromosome breaks and gaps
compared to parental cells (Fig. 5E). Such results were consistent with the observations made for cells at metaphase (Fig.
5C) and thus support the argument that hRad9 influences the
repair of G2-phase-specific chromosome damage.
Observable chromosome aberrations in cells with reduced
levels of hRad9 do not correlate with a deficiency of S or G2
checkpoints. To determine whether the increase in S-phasespecific IR-induced chromosomal damage is due to defective
cell cycle checkpoints, we first determined whether mammalian
Rad9 inactivation results in loss of the G1 checkpoint. We
found that 293 cells with reduced levels of hRad9 caused by
siRNA or ⌬hRad9 expression showed a significant increase in
G1-phase cells with a decrease in S-phase entry after IR exposure, similar to control cells that showed a significant decrease
in S-phase entry, indicating G1 arrest (Fig. 6A and data not
shown). Similar results were found for Mrad9⫺/⫺ and
Mard9⫹/⫹ cells. These results suggest that Rad9 has no (detectable) influence on the G1 checkpoint in these cell systems.
Exposure to IR causes a transient inhibition of DNA replication. Cells deficient in ATM function exhibit radioresistant
DNA synthesis, an indicator of loss of the S-phase checkpoint
(38). Cells expressing ⌬hRad9 or cells with siRNA-reduced
Rad9 levels, as well as Mrad9⫺/⫺ cells, did show inhibition of
DNA synthesis after IR exposure which was similar to that of
the control cells (Fig. 6B and data not shown). To determine
whether mammalian Rad9 influences the G2 checkpoint, the
efficiency of G2 delay was evaluated by measuring the proportion of cells in mitosis (mitotic index) after irradiation. Cells
expressing ⌬Rad9 or having reduced levels of hRad9 showed
no significant difference in the mitotic index after irradiation
with 2 Gy of IR compared to the control, suggesting that
inactivation of mammalian Rad9 does not lead to a defective
G2 checkpoint (Fig. 6C). These results suggest that Rad9 has a
critical role in DNA damage repair rather than in IR-induced
cell cycle checkpoint control. Such results are consistent with
previous studies of Mrad9⫺/⫺ mouse ES cells, which demonstrate that there is no major problem with IR-induced G2
checkpoint control initiation, only a defect in the prolonged
maintenance of the checkpoint, consistent with a defect in
DNA repair (23). Thus, the enhanced chromosomal damage
seen in mammalian cells with inactivated Rad9 cannot be attributed to defective cell cycle checkpoints, again suggesting
that altered DNA repair is the more likely explanation.
IR-induced phosphorylation of ATM, as well as Chk2, is not
influenced by knockdown of hRad9. In mammalian cells, in
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FIG. 5—Continued.
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response to DNA damage, ATM gets autophosphorylated and
phosphorylates various proteins that control G1-, S-, and G2phase cell cycle arrest (16, 38, 57). We examined whether
inactivation of hRad9 influences IR-induced ATM phosphorylation at Ser-1981 in 293 cells. ATM phosphorylation by IR
was found in cells with or without knockdown of hRad9 (Fig.
7). We also examined whether inactivation of hRad9 influences
ATM-mediated, IR-induced phosphorylation of Chk2 in 293
cells. ATM phosphorylates Chk2 on Thr-68 in response to
DNA damage (31). Cells with or without reduced levels of

hRad9 showed no difference in the IR-induced phosphorylation of Chk2 at Thr-68 (Fig. 7). Since hRad9 function does not
influence IR-induced ATM or ATM-mediated Chk2 phosphorylation, such results argue further against a role for hRad9
in cell cycle checkpoint control but thus support a role in DNA
damage repair.
There are two major ways to maintain the ends of chromosomes in yeast and mammalian nuclei: mechanisms related to
telomerase and recombination. Without telomerase or recombination, cells enter a state of growth arrest. Since mammalian
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FIG. 6. Cell cycle checkpoint analysis. (A) Human 293 cells were
exposed to 8 Gy of IR. Twelve hours following irradiation, cells were
pulse-labeled with BrdU for 30 min. The proportion of S-phase cells
was determined. The percentage of S-phase cells in the irradiated
culture relative to those in the unirradiated control is shown. The
results represent the mean of three experiments. For each independent
experiment, 200 cells were examined. Black bars represent unirradiated control cells that enter into S phase, as they are BrdU positive.
Dashed bars represent cells that enter into S phase postirradiation, and
their percentage is determined by dividing the number of S-phase
irradiated cells by the number of S-phase unirradiated cells. (B) Sphase checkpoint was determined as radioresistant DNA synthesis
after exposure to IR. 293 cells were irradiated at the doses indicated.
The rate of DNA synthesis was determined 1 h postirradiation by
pulse-labeling with [3H]thymidine for 30 min. The value of the unirradiated control was set to 100% for each cell type. The mean and
standard deviation of triplicate experimental points are shown.
(C) Comparison of the mitotic index among cells after treatment with
2 Gy of IR. Populations were examined for the frequency of mitotic
cells at different times postirradiation. The mean represents the value
from three independent experiments. For each experiment, 200 metaphases were scored. Note that the mitotic index decreased in cells
whether or not hRad9 levels were wild type.
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Rad9 inactivation did not influence telomerase activity, we
tested whether hRad9 was involved in NHEJ or HR.
hRad9 has no impact on NHEJ. The aforementioned results
established a role for hRad9 in S- and G2-phase-specific DNA
damage repair. It has been suggested that the cell cycle could
influence DSB repair since NHEJ acts predominantly in G1
and HR acts in S and G2 (61). To determine whether the
hRad9 protein is directly involved in DNA end joining, we
used a well-characterized in vitro assay that involves the rejoining of DNA ends of a plasmid in 293 cell extracts as previously described (5, 54). Plasmid pUC19 was digested with
SalI, and DNA end joining was performed as previously described (5, 54). hRad9 in 293 cell extracts was depleted by
immunoprecipitation with hRad9 antibody. Complete immunodepletion of hRad9 was confirmed by Western analysis (Fig.
8A). hRad9-immunodepleted extracts or extracts from Rad9
siRNA-treated cells were used to assay DNA end-joining activity. No difference in this activity was found in extracts with or
without hRad9 (Fig. 8B). These results suggest that hRad9
does not have a role in the DNA end-joining process. However, these observations did not rule out a role for hRad9 in
chromosomal recombination.
hRad9 interacts with hRad51 and influences HR repair. The
defect in chromosome repair found in hRad9 knockdown cells
in S and G2 suggested a role for hRad9 in HR since this
process predominates in cells in these phases of the cell cycle,
when sister chromatids are available as a template for repair. It
is known that the hRad9-hHus1-hRad1 complex is loaded onto
damaged DNA in an hRad17-dependent manner (73) and
hRad9 colocalizes with ␥-H2AX at those sites (19). hRad9 also
colocalizes with telomeric DNAs and promyelocytic leukemia
bodies in ALT cells (35). ALT cells have abundant telomeric
circles, suggesting that frequent t-loop HR events could promote rolling-circle replication of telomeres in the absence of
telomerase. Wang and coworkers (68) demonstrated that tloop deletion by HR influences mammalian telomeres. A key
feature of HR is DNA strand invasion, which is catalyzed by
the Rad51 protein coating single-stranded DNA; however, the
exact roles of the many accessory proteins that facilitate this

FIG. 8. hRad9 is not essential for NHEJ. Depletion of hRad9 was
achieved by two different approaches: immunodepletion and use of
hRad9 siRNA. (A) Immunodepletion of hRad9 from whole 293-cell
extracts as determined by immunoblotting. The extracts were precipitated with protein A-Sepharose beads only (lane 1), with preimmune
serum (lane 2), and with hRad9-depleted whole-cell extract (depleted
with hRad9 antibody) (lane 3). (B) Ethidium bromide-stained agarose
gels show the results of end-joining assays. Plasmid puc19 DNA was
linearized by digestion with SalI. The positions of monomer and dimer
plasmids are indicated to the right of the gel. Lane 1, molecular weight
(MW) markers; lane 2, only plasmid DNA; lane 3, only cell lysate; lane
4, cell lysate and DNA; lane 5, cell lysate with wortmannin and DNA;
lane 6, immunoglobulin G (IgG) depleted in cell lysate and then added
DNA; lane 7, DNA protein kinase (DNA-PK) depleted in cell lysate
and then added DNA; lane 8, cell lysates of cells with control siRNA
and plasmid DNA; lane 9, cell lysate from cells with hRad9 siRNA and
plasmid DNA; lane 10, immunoglobulin G (IgG) depleted in cell lysate
and DNA; lane 11, hRad9 depleted in 293 cell lysates and DNA; lane
12, hRad9 depleted in MCF-7 cells and DNA.

process are not known. Rad51D is involved in the maintenance
of telomeres. Rad51 can form distinct nuclear foci in response
to IR exposure (63). These foci can be visualized by microscopy and are thought to be sites where repair reactions take
place (62). Since hRad9 influences telomere stability, as well as
DNA damage repair, we determined whether hRad9 interacts
with Rad51.
Analysis of anti-hRad9 immunoprecipitates with antihRad51 antibody demonstrated interaction between the two
(Fig. 2D). When cells were exposed to IR, the association of
hRad9 with hRad51 was unaffected (data not shown). These
observations suggest that interaction of hRad9 with hRad51, as
well as with TRF2, occurs prior to induction of DNA damage
by the application of exogenous agents.
The interaction of hRad9 with hRad51 suggests that hRad9
may have a role in HR. Therefore, we measured HR by examining the frequency of reconstitution of a GFP reporter gene
within a chromosomally integrated plasmid substrate in cells
with or without reduced levels of hRad9. Following I-SceI
transfection, cells containing the pDR-GFP substrate demonstrated a ⬎80-fold increase in the number of GFP-positive
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FIG. 7. hRad9 is not required for IR-induced phosphorylation of
ATM and Chk2. (A) 293 cells with or without hRad9 knockdown were
irradiated with 2 Gy of IR. Cell extracts were immunoblotted with
anti-ATM antibodies and anti-p-Ser-1981–ATM antibody. (B) 293
cells with or without hRad9 knockdown were irradiated with 5 Gy of
IR. Cell extracts were immunoblotted with anti-Chk2 antibody and
anti-p-T68–Chk2 antibodies. No difference in cells with or without
hRad9 was observed for IR-induced phosphorylation of ATM or Chk2.
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members compared with cells containing the control vector,
indicating that almost all of the GFP-positive cells resulted
from DSB-induced recombination (Fig. 9). pDR-GFP cells
treated with hRad9 siRNA had a three- to fourfold reduction
in the number of GFP positives in comparison to control transfected cells (t test, P ⬍ 0.001), providing strong evidence that
hRad9 affects the HR pathway for DNA DSB repair.
DISCUSSION
The function of mammalian Rad9, a gene involved in sensing DNA damage, was examined in the context of chromosome
stability and DNA repair in mammalian cells. Human cells in
which hRad9 was inactivated by expression of ⌬hRad9, or
levels of the protein were reduced by siRNA, or mouse cells
with Mrad9 deleted (23) were used. A cDNA fragment encoding aa 269 to 391 of hRad9 was expressed in different human
cells, which were subsequently examined for various end
points. We found that the C-terminal fragment of hRad9 (aa
269 to 391) demonstrated dominant negative activity for almost all of the assays employed. Thus, expression of this fragment might block the interaction of wild-type hRad9 with
other proteins and thus has a dominant negative function. This
function of the hRad9 fragment is consistent with the previously described observation of Wang and coworkers (67), who
reported that the C-terminal region of hRad9 interacts with
other proteins. We found that, indeed, the frequencies of chromosomal abnormalities, such as chromosome end-to-end associations and chromosomal breaks, were higher in cells with
inactivated mammalian Rad9. These chromosomal aberrations
appear to involve dysfunctional telomeres, as a significant
number of cells showed TAs. Thus, the results suggest that

abrogating the function of mammalian Rad9, which is implicated in mediating DNA damage-sensing checkpoints, increases the frequency of unrepaired chromosomal aberrations
that can lead to an increase in the number of telomere fusions.
This mechanism might contribute to the inviability of mouse
embryonic fibroblasts when Mrad9 is inactivated (23). The
frequencies of spontaneous, as well as IR-induced, chromosomal aberrations were dramatically higher in cells with inactivated Rad9 relative to those in controls, suggesting that loss
of telomere function occurred by breakage near telomeres,
rather than by a telomerase-based mechanism. This is supported by our finding that knockdown of hRad9 does not
influence telomerase activity (data not shown). hRad9 forms a
heterotrimer with Hus1 and Rad1, which is loaded onto DNA
by Rad17-mediated mechanisms, and these proteins are evolutionarily conserved. Interestingly, studies with S. pombe, S.
cerevisiae, and Caenorhabditis elegans orthologues also indicate
roles for these proteins in telomere metabolism (1, 11, 25, 28,
36).
It is important to note that in cells with both alleles of Rad9
inactivated, frequent chromosome breakage with complete loss
of telomeric repeats in some chromosomes, as well as chromosome end fusions, occurred under normal growth conditions in
the absence of exogenous genotoxic challenges (Fig. 2 and
Table 1). The fact that the G1 checkpoint was operative in cells
with reduced levels of Rad9 is supported by the observations
that irradiation induced comparable frequencies of cells in G1
and S phase compared to those cells with normal levels of
hRad9 (Fig. 6A). Furthermore, cells with reduced levels of
Rad9 did not show any defect in the S-phase-specific cell cycle
checkpoint, as such cells did not differ from control cells for
radioresistant DNA synthesis (Fig. 6B). The mitotic index after
irradiation was identical in cells with or without functional
Rad9, indicating that mammalian Rad9 inactivation does not
influence the G2 checkpoint in the cell lines studied (Fig. 6C).
hRad9 knockdown had no influence on IR-induced ATM Ser1981 phosphorylation or Chk2 Thre-68 phosphorylation, supporting the argument that mammalian Rad9 has a minimum
role in cell cycle checkpoint control postirradiation. In contrast, there was a clear and significant difference in the chromosome aberration frequency if log-phase cells were irradiated, and mitoses shortly thereafter were monitored; at 4 h
postirradiation, there was a 1.8-fold difference in the frequencies of S-phase aberrations/metaphase between cells with and
without Rad9 fully functional (Fig. 5B). Furthermore, when
G2-induced aberrations were monitored after irradiation, cells
with reduced levels of Rad9 showed higher frequencies of
aberrations in the same time span compared to controls, indicating very inefficient repair (Fig. 5C). Utilizing the PCC technique, we found that there was no difference in the kinetics of
repair or the residual number of chromosome breaks in G1phase cells with or without reduced levels of hRad9 (Fig. 5D);
however, cells deficient in Rad9 had a higher frequency of
chromosome gaps and breaks in the G2 phase (Fig. 5E). Consistent with these data, survival studies demonstrated that cells
in the S and G2 phases were sensitive to irradiation if Rad9 was
inactivated (Fig. 3C and D). These data, taken together, reinforce the idea that in cells with hRad9 knockdown, chromosomal damage that might occur during the S or G2 phase could
be due to defective chromosome repair (Fig. 5B, C, and E). In
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FIG. 9. hRad9 knockdown influences HR. Impaired I-SceI-induced HR in hRad9-deficient MCF-7 cells was found. HR was measured by dual-color flow cytometric detection of GFP-positive cells.
HR frequencies are shown with (⫹) or without (⫺) I-SceI induction
for untreated cells, for cells treated with control siRNA, and for cells
treated with hRad9-specific siRNA. hRad9-deficient and BRCA1-deficient cells show similar reductions in HR. The knockdown of BRCA1
by BRCA1 siRNA in MCF-7 cells has been described previously (72).
The results presented are the mean and standard error from four
independent experiments.
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The association of hRad9 with TRF2 provides further evidence that hRad9 may have a role in maintaining the stability
of telomeres. Although knockdown of hRad9 has a minimal
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cells. This is supported by our demonstration of a physical
interaction between hRad9 and hRad51. In fact, Shinohara
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Mrad9⫹/⫹ cells. Moreover, the high frequency of chromatid
gaps and breaks in hRad9-inactivated cells supports a role for
the protein in HR repair. Inactivation of mammalian Rad9
could thus contribute, at least in part, to the radiosensitivity,
genomic instability, and loss of telomeres observed by mediating the abrogation of HR repair.
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